Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 3
1993 3
1995 2
1996 6
1997 5
1998 5
1999 5
2000 2
2001 2
2002 5
2003 2
2004 1
2005 2
2006 1
2007 2
2009 1
2013 3
2014 9
2015 11
2016 7
2017 6
2018 9
2019 4
2020 1
2021 5
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Non-24-hour Sleep-Wake Rhythm Disorder.
Abbott SM. Abbott SM. Neurol Clin. 2019 Aug;37(3):545-552. doi: 10.1016/j.ncl.2019.03.002. Epub 2019 Apr 30. Neurol Clin. 2019. PMID: 31256788 Review.
Non-24-hour sleep-wake rhythm disorder is a circadian rhythm sleep-wake disorder characterized by an inability to entrain to the 24-hour environment. Patients present with complaints of insomnia or hyper …
Non-24-hour sleep-wake rhythm disorder is a circadian rhythm sleep-wake …
Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management.
Quera Salva MA, Hartley S, Léger D, Dauvilliers YA. Quera Salva MA, et al. Front Neurol. 2017 Dec 18;8:686. doi: 10.3389/fneur.2017.00686. eCollection 2017. Front Neurol. 2017. PMID: 29326647 Free PMC article. Review.
Several aspects of human physiology and behavior are dominated by 24-h circadian rhythms with key impacts on health and well-being. These include mainly the sleep-wake cycle, vigilance and performance patterns, and some hormone secretions. ...The diagnosis of …
Several aspects of human physiology and behavior are dominated by 24-h circadian rhythms with key impacts on health and well-being. T …
Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.
Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Auger RR, et al. J Clin Sleep Med. 2015 Oct 15;11(10):1199-236. doi: 10.5664/jcsm.5100. J Clin Sleep Med. 2015. PMID: 26414986 Free PMC article.
A systematic literature review and meta-analyses (where appropriate) were performed and the GRADE approach was used to update the previous American Academy of Sleep Medicine Practice Parameters on the treatment of intrinsic circadian rhythm sleep-wake diso …
A systematic literature review and meta-analyses (where appropriate) were performed and the GRADE approach was used to update the previous A …
Non-24-Hour Sleep-Wake Rhythm Disorder in Sighted and Blind Patients.
Uchiyama M, Lockley SW. Uchiyama M, et al. Sleep Med Clin. 2015 Dec;10(4):495-516. doi: 10.1016/j.jsmc.2015.07.006. Sleep Med Clin. 2015. PMID: 26568125 Review.
Non-24-hour sleep-wake rhythm disorder (N24SWD) is a cyclic debilitating circadian rhythm sleep disorder characterized by an inability to sleep on a 24-hour schedule. Individuals isolated from a 24-hour light-dark cyc …
Non-24-hour sleep-wake rhythm disorder (N24SWD) is a cyclic debilitating circadian rhyth …
Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
Neubauer DN. Neubauer DN. Drugs Today (Barc). 2015 Jan;51(1):29-35. doi: 10.1358/dot.2015.51.1.2258364. Drugs Today (Barc). 2015. PMID: 25685859 Review.
Tasimelteon (Hetlioz), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be approved by the U.S. Food and Drug Administration (FDA) for the treatment of non-24-hour sleep-wake disorder (non- …
Tasimelteon (Hetlioz), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be approved by the …
Behaviorally and environmentally induced non-24-hour sleep-wake rhythm disorder in sighted patients.
Emens JS, St Hilaire MA, Klerman EB, Brotman DJ, Lin AL, Lewy AJ, Czeisler CA. Emens JS, et al. J Clin Sleep Med. 2022 Feb 1;18(2):453-459. doi: 10.5664/jcsm.9612. J Clin Sleep Med. 2022. PMID: 34402783 Free PMC article.
STUDY OBJECTIVES: To determine whether there was evidence of circadian or sleep-regulatory dysfunction in sighted individuals with non-24-hour sleep-wake rhythm disorder. METHODS: Three sighted individuals with signs and/or symptom …
STUDY OBJECTIVES: To determine whether there was evidence of circadian or sleep-regulatory dysfunction in sighted individuals with non …
Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
Johnsa JD, Neville MW. Johnsa JD, et al. Ann Pharmacother. 2014 Dec;48(12):1636-41. doi: 10.1177/1060028014550476. Epub 2014 Sep 9. Ann Pharmacother. 2014. PMID: 25204464 Review.
OBJECTIVE: To examine the efficacy of tasimelteon for the treatment of non-24-hour sleep-wake disorder using evidence from controlled clinical trials. ...DATA SYNTHESIS: A phase II trial (n = 39) evaluated the effects of tasimelteon versu …
OBJECTIVE: To examine the efficacy of tasimelteon for the treatment of non-24-hour sleep-wake disorder …
Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals.
Keating GM. Keating GM. CNS Drugs. 2016 May;30(5):461-8. doi: 10.1007/s40263-016-0330-y. CNS Drugs. 2016. PMID: 27003694 Review.
Tasimelteon (Hetlioz()) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) (free-running disorder). In two randomized, double-masked, multicentre, phase III trials, totally …
Tasimelteon (Hetlioz()) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep- …
110 results